The coronavirus disease 2019 (COVID-19) pandemic has presented a serious public health
threat, resulting in more than 600 million infections worldwide and 6 million fatalities. 1 The …

Significant time has passed since the coronavirus disease of 2019 (COVID-19) pandemic
outbreak, which led to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …

Post-acute sequelae of COVID-19 (PASC) are conditions that occur or remain at least 28
days after SARS-CoV-2 infection. While some risk factors for PASC have been identified …

Abstract According to the World Health Organization, severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) has already infected more than 400 million people and …

Beyond the acute illness caused by severe acute respiratory coronavirus 2 (SARS-CoV-2)
infection, about one-fifth of infections result in long-term persistence of symptoms despite the …

We have read with interest the recent article by Favalli et al. published in Autoimmunity
Reviews [1]. We agree with the Authors that Corona Virus Disease 2019 (COVID-19) …

The association between infectious diseases and autoimmunity has long been reported.
Specifically, during the coronavirus disease 2019 (COVID‐19) pandemic, this relation was …

Background The immunopathological pathways enabling post-coronavirus disease 2019
(COVID-19) syndrome (PCS) development are not entirely known. We underwent a …

Currently, few evidences have shown the possible involvement of autoimmunity in patients
affected by coronavirus disease 2019 (COVID‐19). In this study, we elucidate whether …

The clinical spectrum of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection ranges from asymptomatic to critical illness, which may include severe sepsis and …